111 related articles for article (PubMed ID: 12543794)
21. Association between HLA-DRB1 polymorphism, high-risk HPV infection and cervical neoplasia in southern Chinese.
Chan PK; Cheung TH; Lin CK; Siu SS; Yim SF; Lo KW; Cheung JL; Tam AO; Tang JW
J Med Virol; 2007 Jul; 79(7):970-6. PubMed ID: 17516530
[TBL] [Abstract][Full Text] [Related]
22. Human papillomavirus and vulval intra-epithelial neoplasia.
Gastrell FH; McConnell DT
Best Pract Res Clin Obstet Gynaecol; 2001 Oct; 15(5):769-82. PubMed ID: 11563872
[TBL] [Abstract][Full Text] [Related]
23. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
Branca M; Garbuglia AR; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K;
Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
[TBL] [Abstract][Full Text] [Related]
24. Polymorphisms for chemical metabolizing genes and risk for cervical neoplasia.
Sierra-Torres CH; Au WW; Arrastia CD; Cajas-Salazar N; Robazetti SC; Payne DA; Tyring SK
Environ Mol Mutagen; 2003; 41(1):69-76. PubMed ID: 12552594
[TBL] [Abstract][Full Text] [Related]
25. Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections.
Hawes SE; Critchlow CW; Faye Niang MA; Diouf MB; Diop A; Touré P; Aziz Kasse A; Dembele B; Salif Sow P; Coll-Seck AM; Kuypers JM; Kiviat NB
J Infect Dis; 2003 Aug; 188(4):555-63. PubMed ID: 12898443
[TBL] [Abstract][Full Text] [Related]
26. Spontaneous regression of grade 3 vulvar intraepithelial neoplasia associated with human papillomavirus-16-specific CD4(+) and CD8(+) T-cell responses.
Bourgault Villada I; Moyal Barracco M; Ziol M; Chaboissier A; Barget N; Berville S; Paniel B; Jullian E; Clerici T; Maillère B; Guillet JG
Cancer Res; 2004 Dec; 64(23):8761-6. PubMed ID: 15574788
[TBL] [Abstract][Full Text] [Related]
27. Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2.
Hawes SE; Critchlow CW; Sow PS; Touré P; N'Doye I; Diop A; Kuypers JM; Kasse AA; Kiviat NB
J Natl Cancer Inst; 2006 Jan; 98(2):100-9. PubMed ID: 16418512
[TBL] [Abstract][Full Text] [Related]
28. Activation of the ERK/MAP kinase pathway in cervical intraepithelial neoplasia is related to grade of the lesion but not to high-risk human papillomavirus, virus clearance, or prognosis in cervical cancer.
Branca M; Ciotti M; Santini D; Bonito LD; Benedetto A; Giorgi C; Paba P; Favalli C; Costa S; Agarossi A; Alderisio M; Syrjänen K;
Am J Clin Pathol; 2004 Dec; 122(6):902-11. PubMed ID: 15539382
[TBL] [Abstract][Full Text] [Related]
29. HLA-DRB1 alleles and cervical squamous cell carcinoma: experimental study and meta-analysis.
Yang YC; Chang TY; Lee YJ; Su TH; Dang CW; Wu CC; Liu HF; Chu CC; Lin M
Hum Immunol; 2006; 67(4-5):331-40. PubMed ID: 16720214
[TBL] [Abstract][Full Text] [Related]
30. Integration of HPV-16 and HPV-18 DNA in vulvar intraepithelial neoplasia.
Hillemanns P; Wang X
Gynecol Oncol; 2006 Feb; 100(2):276-82. PubMed ID: 16300821
[TBL] [Abstract][Full Text] [Related]
31. Human papillomavirus type distribution in vulval intraepithelial neoplasia determined using PapilloCheck DNA Microarray.
Bryant D; Rai N; Rowlands G; Hibbitts S; Jones J; Tristram A; Fiander A; Powell N
J Med Virol; 2011 Aug; 83(8):1358-61. PubMed ID: 21618551
[TBL] [Abstract][Full Text] [Related]
32. Tumor necrosis factor A and MHC class I chain related gene A (MIC-A) polymorphisms in Swedish patients with cervical cancer.
Ghaderi M; Nikitina Zake L; Wallin K; Wiklund F; Hallmans G; Lenner P; Dillner J; Sanjeevi CB
Hum Immunol; 2001 Oct; 62(10):1153-8. PubMed ID: 11600224
[TBL] [Abstract][Full Text] [Related]
33. Association between human papillomavirus 16 E6 variants and human leukocyte antigen class I polymorphism in cervical cancer of Swedish women.
Zehbe I; Mytilineos J; Wikström I; Henriksen R; Edler L; Tommasino M
Hum Immunol; 2003 May; 64(5):538-42. PubMed ID: 12691704
[TBL] [Abstract][Full Text] [Related]
34. Association of HLA-DRB1, interleukin-6 and cyclin D1 polymorphisms with cervical cancer in the Swedish population--a candidate gene approach.
Castro FA; Haimila K; Sareneva I; Schmitt M; Lorenzo J; Kunkel N; Kumar R; Försti A; Kjellberg L; Hallmans G; Lehtinen M; Hemminki K; Pawlita M
Int J Cancer; 2009 Oct; 125(8):1851-8. PubMed ID: 19585495
[TBL] [Abstract][Full Text] [Related]
35. Association of HLA-DRB1/DQB1 polymorphism with high-risk HPV infection and cervical intraepithelial neoplasia women from Shanghai.
Zhao J; Wang L; Lin H; Yu W; Xu X; Hu H; Zhu L; Han L; Li F
Int J Clin Exp Pathol; 2018; 11(2):748-756. PubMed ID: 31938161
[TBL] [Abstract][Full Text] [Related]
36. HLA-DRB1*1602 allele is positively associated with HPV cervical infection in Bolivian Andean women.
Cervantes J; Lema C; Valentina Hurtado L; Andrade R; Hurtado Gomez L; Torrico L; Zegarra L; Quiroga G; Asturizaga D; Dulon A; Prada R; Panoso W; Yashiki S; Fujiyoshi T; Sonoda S
Hum Immunol; 2003 Sep; 64(9):890-5. PubMed ID: 12941545
[TBL] [Abstract][Full Text] [Related]
37. Alterations in classical and nonclassical HLA expression in recurrent and progressive HPV-induced usual vulvar intraepithelial neoplasia and implications for immunotherapy.
van Esch EM; Tummers B; Baartmans V; Osse EM; Ter Haar N; Trietsch MD; Hellebrekers BW; Holleboom CA; Nagel HT; Tan LT; Fleuren GJ; van Poelgeest MI; van der Burg SH; Jordanova ES
Int J Cancer; 2014 Aug; 135(4):830-42. PubMed ID: 24415578
[TBL] [Abstract][Full Text] [Related]
38. Differentiating normal and abnormal findings of the vulva.
Apgar BS; Cox JT
Am Fam Physician; 1996 Mar; 53(4):1171-80. PubMed ID: 8629564
[TBL] [Abstract][Full Text] [Related]
39. HLA control in the progression of human papillomavirus infections.
Breitburd F; Ramoz N; Salmon J; Orth G
Semin Cancer Biol; 1996 Dec; 7(6):359-71. PubMed ID: 9284528
[TBL] [Abstract][Full Text] [Related]
40. HLA DQ-DR haplotype and susceptibility to cervical carcinoma: indications of increased risk for development of cervical carcinoma in individuals infected with HPV 18.
Allen M; Kalantari M; Ylitalo N; Pettersson B; Hagmar B; Scheibenpflug L; Johansson B; Petterson U; Gyllensten U
Tissue Antigens; 1996 Jul; 48(1):32-7. PubMed ID: 8864172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
